But Wentworth said during a March earnings call that Walgreens had recorded a $5.8 billion impairment charge during the last quarter related to VillageMD, and that VillageMD would be closing 160 ...
Walgreens (NASDAQ:WBA) saw its stock rise 5% on Monday, May 13, following the reports that it has contacted potential buyers for the Boots business. Boots is a UK-based drugstore chain, and it ...
Walgreens announced last week that it would close 160 of its VillageMD clinics after it recorded a nearly $6 billion non-cash impairment charge in the second quarter, the company said. >> Read ...
Dividend stocks help you to make money with no effort on your part. And that passive income can be incredibly powerful if ...
May 15 (Reuters) - U.S. pharmacy chain operator Walgreens Boots Alliance (WBA.O) , opens new tab said on Wednesday it has launched its own brand of popular overdose reversal drug, naloxone, which ...
As of 12:07 PM EDT. Market Open. Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health ...
Walgreens is set to offer a cheaper version of an important opioid reversal drug at its stores soon, according to Wednesday press release. “Walgreens today announced it is expanding access to an ...
Unlike Walgreens, Pfizer recently raised its dividend payout for the 15th year in a row. At recent prices, it offers a 5.8% ...
Walgreens Boots Alliance is once again attempting to sell its Boots pharmacies in the United Kingdom ... [+] as the company chief executive officer Tim Wentworth and his new management team review ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Walgreens said its generic version of Narcan will be priced at $34.99. Walgreens Boots Alliance announced Wednesday that it plans to sell its own generic version of the overdose reversal drug Narcan.